News

We are delighted to share that Culturon and Qkine have joined forces to deliver cutting-edge solutions for the stem cell and life science industries.

Class of 2024: celebrating the products launched in 2024 including expanding our hematopoietic range and adding tuna, salmon and eel FGF-2!

Through its pioneering cell-type-specific immortalization technology, inscreenex empowers scientists to overcome the limitations of primary cell cultures, offering long-lasting and functional cell lines that are ideal for applications in drug discovery, disease modeling, and personalized medicine. Collaboration with Qkine merges their expertise with that of Qkine in complex protein manufacturing and engineering to allow testing and validation of cell responses in disease modelling.

‍Qkine, a leading manufacturer of high purity bioactive proteins, is pleased to announce its new sales distribution agreement with leading Turkish cell biology and stem cell reagent supplier Pitagen.

Qkine is pleased to announce a new UK & Ireland sales distribution agreement with SLS, the largest independent supplier of laboratory equipment, chemicals, and consumables in the UK.

Qkine are delighted that our eel FGF-2 proteins have elicited interest in Japan, recently the Nikkei Biotechnology & Business magazine have published an article focussing on the 145 and 154 amino acid versions of eel FGF-2, and the contribution Qkine species specific growth factors can have on the cultured seafood industry.

Qkine announces the provision of a new range of high quality food grade growth factors as part of our commitment to driving innovation in the functional recombinant growth factor supply chain for emerging sectors including cultivated meat, fish, fat and dairy.

NAPIC is a £38m centre dedicated to developing acceptable and planet-friendly alternatives to animal proteins led by researchers from the University of Leeds, James Hutton Institute, University of Sheffield and Imperial College London.

In this edition, we are excited to announce a price freeze moving into 2025, our win of Scale-up of the Year in the Cambridge Business Awards. We also share our latest hematopoietic stem cells blog, new products IL-2 and activin E PLUS and a new application note on growth factor stability.

As part of our commitment to supporting our customers and their science in economically difficult times, we have decided to hold our prices into 2025.

Our latest investment in our mission at Qkine to produce the highest quality growth factors for research. The most state-of-the-art automated system which fills, labels and caps vials with minimal manual intervention.

Qkine winners of Cambridge Business Awards 2024 – Scale-up of the Year On the 26th September 2024, Qkine representatives Catherine Elton, CEO and Luana Ferrara, Head of…